NOTE 11 - CUSTOMER DEPOSITS	12 Months Ended
Dec. 31, 2012
Deferred Revenue Disclosure [Text Block]	NOTE 11 – CUSTOMER DEPOSITS In November 2011, the Company entered into a production manufacturing contract with SMTC Corporation (SMTC), headquartered in Toronto, Canada. SMTC maintains manufacturing facilities in Canada, the United States, Mexico and China. In January 2012, the Company initiated its first purchase order for five production validation units to be manufactured. The production validation units were used for regulatory compliance and licensing validation, additional testing and early delivery purposes. As of December 31, 2011, the Company received two purchase orders and related customer deposits totaling $40,000 to purchase the AsepticSure hospital disinfection systems. The Company took delivery of its first disinfection systems early in 2012. As of December 31, 2011, these customer deposits were reflected as current liabilities. In September 2012, the Company changed manufacturers and entered into a contract with Transformix Engineering (Transformix) to manufacture the Company’s devices. Transformix is a specialty engineering and manufacturing company located in Kingston, Ontario, Canada. This change in manufacturers was necessitated to address delays in product delivery and quality control issues encountered under the earlier agreement. The Company took delivery of the first AsepticSure systems built by Transformix in December 2012. Transformix expects to ramp up production in order to meet estimated sales orders of the AsepticSure system for the second quarter of 2013.

NOTE 11 - CUSTOMER DEPOSITS

12 Months Ended

Dec. 31, 2012

Deferred Revenue Disclosure [Text Block]

NOTE 11 – CUSTOMER DEPOSITS

In November 2011, the Company entered into a production manufacturing contract with SMTC Corporation (SMTC), headquartered in Toronto, Canada. SMTC maintains manufacturing facilities in Canada, the United States, Mexico and China. In January 2012, the Company initiated its first purchase order for five production validation units to be manufactured. The production validation units were used for regulatory compliance and licensing validation, additional testing and early delivery purposes.

As of December 31, 2011, the Company received two purchase orders and related customer deposits totaling $40,000 to purchase the AsepticSure hospital disinfection systems. The Company took delivery of its first disinfection systems early in 2012. As of December 31, 2011, these customer deposits were reflected as current liabilities.

In September 2012, the Company changed manufacturers and entered into a contract with Transformix Engineering (Transformix) to manufacture the Company’s devices. Transformix is a specialty engineering and manufacturing company located in Kingston, Ontario, Canada. This change in manufacturers was necessitated to address delays in product delivery and quality control issues encountered under the earlier agreement. The Company took delivery of the first AsepticSure systems built by Transformix in December 2012. Transformix expects to ramp up production in order to meet estimated sales orders of the AsepticSure system for the second quarter of 2013.

- Definition

The entire disclosure for deferred revenues at the end of the reporting period, and description and amounts of significant changes that occurred during the reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References+ Details